Skip to content

Clinical trials

Phase 3 Hepatitis C trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Phase: Phase 3 Country / region: Germany Clear all

44 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20081
20091
20101
201111
201210
20131
20143
20155
20161
20174
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences10
Bristol-Myers Squibb6
Janssen R&D Ireland6
AbbVie5
Debiopharm International SA3
GlaxoSmithKline3
Boehringer Ingelheim2
Human Genome Sciences Inc.2
Janssen-Cilag International NV2
Vertex Pharmaceuticals Incorporated2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C44
Hepatitis C, Chronic14
Fibrosis5
Hepatitis5
Bronchiolitis Obliterans Syndrome2
Liver Diseases2
Virus Diseases2
Digestive System Diseases1
Enterovirus Infections1
Flaviviridae Infections1

Trials

Showing 1 to 25 of 44. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.